These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33530834)

  • 1. Small RNA-directed DNA elimination: the molecular mechanism and its potential for genome editing.
    Bastiaanssen C; Joo C
    RNA Biol; 2021 Nov; 18(11):1540-1545. PubMed ID: 33530834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A domesticated PiggyBac transposase interacts with heterochromatin and catalyzes reproducible DNA elimination in Tetrahymena.
    Vogt A; Mochizuki K
    PLoS Genet; 2013; 9(12):e1004032. PubMed ID: 24348275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed DNA elimination in Tetrahymena: a small RNA-mediated genome surveillance mechanism.
    Kataoka K; Mochizuki K
    Adv Exp Med Biol; 2011; 722():156-73. PubMed ID: 21915788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whats, hows and whys of programmed DNA elimination in
    Noto T; Mochizuki K
    Open Biol; 2017 Oct; 7(10):. PubMed ID: 29021213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [RNA directed DNA elimination in Tetrahymena].
    Mochizuki K
    Tanpakushitsu Kakusan Koso; 2006 Dec; 51(16 Suppl):2624-30. PubMed ID: 17471988
    [No Abstract]   [Full Text] [Related]  

  • 7. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversification of small RNA amplification mechanisms for targeting transposon-related sequences in ciliates.
    Mutazono M; Noto T; Mochizuki K
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14639-14644. PubMed ID: 31262823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-RNA-Mediated Genome-wide trans-Recognition Network in Tetrahymena DNA Elimination.
    Noto T; Kataoka K; Suhren JH; Hayashi A; Woolcock KJ; Gorovsky MA; Mochizuki K
    Mol Cell; 2015 Jul; 59(2):229-42. PubMed ID: 26095658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating signaling networks by CRISPR/Cas9-mediated transposable element insertion.
    Vaschetto LM
    Curr Genet; 2018 Apr; 64(2):405-412. PubMed ID: 29032444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenerational function of
    Farley BM; Collins K
    RNA; 2017 Apr; 23(4):530-545. PubMed ID: 28053272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmentally programmed, RNA-directed genome rearrangement in Tetrahymena.
    Mochizuki K
    Dev Growth Differ; 2012 Jan; 54(1):108-19. PubMed ID: 22103557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative Regulators of an RNAi-Heterochromatin Positive Feedback Loop Safeguard Somatic Genome Integrity in Tetrahymena.
    Suhren JH; Noto T; Kataoka K; Gao S; Liu Y; Mochizuki K
    Cell Rep; 2017 Mar; 18(10):2494-2507. PubMed ID: 28273462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transposon-Associated CRISPR-Cas System: A Powerful DNA Insertion Tool.
    Ma W; Xu YS; Sun XM; Huang H
    Trends Microbiol; 2021 Jul; 29(7):565-568. PubMed ID: 33612399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Various Aspects of a Gene Editing System-CRISPR-Cas9.
    Janik E; Niemcewicz M; Ceremuga M; Krzowski L; Saluk-Bijak J; Bijak M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.